Chemical industry – Page 12
-
Business
Setting the standard for calculating indirect emissions
Industry collaboration creates carbon footprinting guidelines for chemical products
-
Business
Alzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
Business
Silky smooth tissue regeneration
Serigen mediproducts is harnessing one of India’s biggest industries to help heal wounds and rebuild flesh and bone
-
Business
An evolution in pharma outsourcing
Contract services firms are becoming increasingly sophisticated and embedded in the ecosystem of drug development
-
Opinion
Contribute to defeating malaria
The Medicines for Malaria Venture needs new compounds for screening and more chemists to join its open-souce drug discovery project
-
Opinion
Do science courses need hands-on labs to be effective?
The practical lab is where abstract theory connects to physical reality
-
Business
Arrayit chief convicted of fraud over blood testing
Mark Schena misrepresented the company’s value to investors and defrauded public and private insurers
-
Business
Nature-inspired crop protection
Plant extracts, proteins and pheromones aiming to replace conventional chemical pesticides
-
Business
Fatal hydrogen sulfide leak at US waste treatment plant
One worker killed and four others injured at US Ecology site in Ohio
-
Opinion
Angela Russell: ‘We have to not be afraid of failing’
The medicinal chemist on thinking like a scientist and knowing where you want to go
-
Business
Rocket-powered carbon dioxide conversion
Barton Blakeley is lowering the carbon footprint of silica and other materials
-
Webinar
Empower your drug design & synthesis with vibrational circular dichroism (VCD)
Discover the advantage and benefits of VCD compared to other analytical techniques and learn how to develop a more efficient workflow
-
Business
J&J to phase out talc-based baby powder worldwide
In the face of thousands of lawsuits, firm will switch to cornstarch-based formulations
-
Business
Protective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
Opinion
Why AlphaFold won’t revolutionise drug discovery
Protein structure prediction is a hard problem, but even harder ones remain
-
Business
UK Reach costs stretch higher for industry
Government assessment suggests deadlines will be delayed and companies will pay billions for compliance data
-
News
Software from Cambridge crystallographic experts could save pharma industry millions
Informatic tools will help drug formulators understand particle behaviour in their final product
-
Opinion
May cause side effects
The dose makes the poison, but understanding unwanted drug interactions is complicated
-
News
US chemical industry responsible for 25% of the country’s GDP
National Academies finds chemical research has ‘outsized economic value’
-
Business
Chemours sues over US PFAS safety limit
Fluoropolymer maker appeals new safety standard for GenX, calling it ‘scientifically unsound’